You are here: Industry Insights > pharmaceutical companies

News List

Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
The Dynamic Diabetes and Metabolic Disorder Treatment Landscape Daivd Orchard Webb/PharmaSources
July 03, 2023
Diabetes is a chronic medical condition characterized by high levels of glucose in the blood.
Analysis on the Construction of Sustainable Development Capacity of Pharmaceutical Enterprises from the Aspect of Investment of R&D Expenses Zhulikou431
December 17, 2021
Recently, semi-annual reports of domestic and foreign pharmaceutical companies have been disclosed one after another. From the data released by major companies, we put aside the highly anticipated...
Discovering Biotechnology: Top 9 Chinese Pharmaceutical Companies in 2020 Deborah Seah
November 04, 2020
China 's pharmaceutical industry garnered a total revenue of about 2.6 trillion yuan in 2019 amounting to an eight percent year-on-year growth.
Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China Pharma Sources Insight
November 02, 2020
With over 4000 pharmaceutical companies, China is the second-largest pharmaceutical industry globally.
New computational method reduces risk of drug formulation worldpharmanews
February 02, 2019
One major factor that determines the efficacy of a drug is the structure that its molecules form in a solid state.
Global Medicine spending to exceeds $1.5 Tn by 2023 biospectrumasia
February 01, 2019
Opioid prescriptions per capita in the US are estimated to decline by one-half to one-third compared to current levels by 2023.
Deloitte finds Pharma returns on R&D reach new low europeanpharmaceuticalreview
January 04, 2019
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010
Innovent buys Chinese rights to Incyte drugs for $40M upfront fiercebiotech
December 18, 2018
Innovent Biologics has bagged the Chinese rights to three clinical-phase oncology and hematology drugs in development at Incyte.
Most pharma firms doing little R&D for poorer patients pharmaphorum
November 22, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.

Previous page 1 2 Next page